A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1992
11/11/1992	EP0512399A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/11/1992	EP0512352A2 Substituted carboxylic acid derivatives
11/11/1992	EP0512024A1 Drugs and use thereof
11/11/1992	CN1066072A 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (cd) indoles
11/11/1992	CN1066071A 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd) indoles
11/11/1992	CN1066068A 4-aryl-3-(heteroarylureido) quinoline derivatives
11/11/1992	CN1066067A Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
11/11/1992	CN1066065A Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
11/11/1992	CN1066062A Pharmaceutical compound
11/11/1992	CN1066060A Pharmaceutical compound
11/11/1992	CA2109524A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
11/11/1992	CA2102802A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
11/11/1992	CA2068261A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/11/1992	CA2068229A1 Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
11/10/1992	US5162543 Hypotensive agents
11/10/1992	US5162533 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same
11/10/1992	US5162359 Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-thion derivatives
11/10/1992	US5162350 Benzothiazolinone compounds
11/10/1992	US5162345 Heterocyclic compounds and their preparation and pharmaceutical formulation
11/10/1992	US5162340 Hypotensive agents, treatment of congestive heart failure
11/10/1992	US5162325 Angiotensin ii antagonists incorporating a substituted benzyl element
11/10/1992	US5162316 Pyrimido[4,5-d]pyrimidine derivatives for use as bronchodilators
11/10/1992	US5162311 Treating epilepsy, psychiatric disorders
11/10/1992	CA2068076A1 Substituted carboxylic acid derivaties
11/10/1992	CA2067567A1 Compounds
11/10/1992	CA2067537A1 Compounds
11/10/1992	CA1310011C 1,4-dihydropyridine derivatives having a nitrogen containing heteroaryl group linked to the two position possessing antihypertensive and antithrombotic activity
11/10/1992	CA1309951C Press coated dhp tablets
11/10/1992	CA1309950C Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
11/09/1992	WO1992019211A2 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
11/09/1992	CA2106968A1 Imidazobenzoquinones and compositions for preventing or treating hypertension or congestive heart failure containing the same
11/08/1992	CA2063895A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan
11/08/1992	CA2063752A1 Angiotensin ii antagonists incorporating a substituted benzyl element
11/04/1992	WO1992019605A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992	EP0511879A1 Pyrazine derivatives
11/04/1992	EP0511867A1 Process for the preparation of simvastatin
11/04/1992	EP0511791A2 Pyrrolopyridine derivatives as Angiotensin inhibitors
11/04/1992	EP0511767A1 Tablets containing compound DUP753
11/04/1992	EP0511297A1 Oxathiane derivatives
11/04/1992	EP0511271A1 Thiazole derivatives
11/04/1992	EP0511270A1 New thiazole derivatives
11/04/1992	CN1065865A Indole and dihydroquinoline potassium channel openers
11/04/1992	CA2108902A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992	CA2067905A1 Benzopyranic compounds, process for the preparation thereof, and pharmaceutical compositions containing them
11/03/1992	CA1309719C Heterocycly1-2-propyn-1-amines
11/03/1992	CA1309718C 5-(6-imidazo[1,2-a]pyridyl)pyridine derivative
11/03/1992	CA1309714C Process for the preparation of (2s,3s)-3-acetoxy-5-(n, n-dimethylaminoethyl)-2-(4-methoxyphenyl)-2,3-dihydro- 1,5-benzothiazepin-4(5h)-one
11/02/1992	CA2067722A1 Process for simvastatin
11/02/1992	CA2067663A1 Pyrazine derivatives
10/1992
10/31/1992	CA2066005A1 Nitrogen derivatives
10/30/1992	WO1992019621A1 Pcp receptor ligands and the use thereof
10/30/1992	CA2109420A1 Pcp receptor ligands and the use thereof
10/30/1992	CA2067307A1 Optimized tablet formulation
10/29/1992	WO1992018545A1 Novel heparin derivatives and process for the preparation thereof
10/29/1992	WO1992018486A1 Improved process for the preparation of [1s-(1r, 2s, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/29/1992	WO1992018462A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
10/29/1992	WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
10/29/1992	WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992	WO1992018092A2 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
10/29/1992	DE4200954A1 New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
10/29/1992	CA2106673A1 Improved process for the preparation of [1s-(1r,2s,3r*)]-n-(4-morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/28/1992	EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992	EP0510948A1 N-Hydroxy ureae as 5-lipoxygenase inhibitors
10/28/1992	EP0510947A1 N-Hydroxy (thio)ureas as 5-lipoxygenase inhibitors
10/28/1992	EP0510813A1 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
10/28/1992	EP0510812A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
10/28/1992	EP0510662A1 bFGF mutein and its production
10/28/1992	EP0510526A1 Use of sulfonamides as drug and new sulfonamides
10/28/1992	EP0510398A2 N-Imidazolyl derivatives of substituted indole
10/28/1992	EP0510052A1 Medicament for treatment of heart failure
10/28/1992	EP0345304B1 Pharmaceutical compositions
10/28/1992	EP0290496B1 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
10/28/1992	EP0221958B1 3-aminopropyloxyphenyl derivatives their preparation and pharmaceutical compositions containing them
10/28/1992	CN1018826B Epsilon-valerolactam, pharmacologically active compositions thereof, processes for preparation thereof and their medical use
10/28/1992	CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
10/27/1992	WO1992019624A1 Antiserotonines, prepartion thereof and medicaments containing them
10/27/1992	WO1992019611A1 Novel benzopyran derivative
10/27/1992	US5159114 Acat inhibitory benzanilides
10/27/1992	US5159104 Reacting 4-acyl simvastatin with aliphatic alcohol and acid
10/27/1992	US5159080 Treatment of heart-circulation disorders
10/27/1992	US5159061 Hypotensive agent, diuretic
10/27/1992	US5158975 Use of stearidonic acid
10/27/1992	US5158967 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
10/27/1992	US5158964 Benzoxazole sulfonamide anti-arrhythmic agents
10/27/1992	US5158959 Decahydroisoquinoline carboxylic acids
10/27/1992	CA2108014A1 4-aryl-3-(heteroarylureido)quinoline derivatives
10/27/1992	CA2103562A1 Antiserotonins, preparation thereof and medicaments containing them
10/27/1992	CA2086322A1 Benzopyran derivative
10/27/1992	CA2066931A1 Bfgf mutein and its production
10/27/1992	CA2063856A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan
10/27/1992	CA1309408C Allylmercaptoacetylsydnonimines, processes for their preparation, and their use
10/26/1992	CA2067288A1 Sulfonamides and their medical use
10/25/1992	WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992	CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/25/1992	CA2066938A1 N-imidazolyl derivatives of substituted indole
10/24/1992	CA2066509A1 N-hydroxy-n-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas
10/24/1992	CA2066508A1 N-hydroxy-n-(3-(2-(halophenylthio)phenyl) prop-2-enyl)-ureas as lipoxygenase inhibitors
10/21/1992	EP0509845A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/21/1992	EP0509795A2 Carbamates of rapamycin
10/21/1992	EP0509769A2 Heterocyclic amides having HLE inhibiting activity

1 ... 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 ... 1595